Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
This will go back to £3+ in few months.
We have NCYT for a guide - NCYT when from 14p to £10+
This is the turning point for us. enjoy investing here.
COVID stocks soar as UK targets 2m British made rapid tests per day
https://www.sharebuyers.co.uk/shares/covid-stocks-soar-as-uk-targets-2m-british-made-rapid-tests-per-day/
Crazy Volume: 3,017,038 - Wow passed 3M now.
Diagnostics sector set to continue to see growth in 2021 and 2022, says broker finnCap
https://www.proactiveinvestors.co.uk/companies/amp/news/939174
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Biden’s plan calls for a newly created Pandemic Testing Board to coordinate a “clear, unified approach” to testing for COVID-19, a marked difference from the Trump administration’s policy of states establishing their own plans with federal support.
Laboratories have ramped up production to more than 2 million tests each day, but stubborn problems persist. Some labs struggle to complete timely tests – particularly when demand surges – because of shortages of critical supplies.
Public health labs largely are not equipped to detect new coronavirus variants such as ones first identified in the United Kingdom and South Africa. And there's debate among testing experts on whether wider use of cheaper but less sensitive rapid tests will be the smartest path out of the pandemic.
Biden issued a flurry of executive orders Thursday, from mask mandates on federal property to reopening schools and accelerating vaccine shipments. Fixing the nation’s disparate testing system "will be the most challenging" of all, said Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials.
WOW - Back to 55p - up 31%
Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/notifications-and-emergency-use-authorizations-faqs-testing-sars-cov-2
Hard truths and important facts': Biden pushes for coronavirus testing reset with $50 billion plan
https://eu.usatoday.com/story/news/health/2021/01/24/bidens-covid-testing-push-calls-more-supplies-and-rapid-tests/4215619001/
Notifications and Emergency Use Authorizations: FAQs on Testing for SARS-CoV-2
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/notifications-and-emergency-use-authorizations-faqs-testing-sars-cov-2
Hard truths and important facts': Biden pushes for coronavirus testing reset with $50 billion plan
https://eu.usatoday.com/story/news/health/2021/01/24/bidens-covid-testing-push-calls-more-supplies-and-rapid-tests/4215619001/
Please keep on selling. we need shares urgently.
I'm not selling until £3
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Biden’s plan calls for a newly created Pandemic Testing Board to coordinate a “clear, unified approach” to testing for COVID-19, a marked difference from the Trump administration’s policy of states establishing their own plans with federal support.
Laboratories have ramped up production to more than 2 million tests each day, but stubborn problems persist. Some labs struggle to complete timely tests – particularly when demand surges – because of shortages of critical supplies.
Public health labs largely are not equipped to detect new coronavirus variants such as ones first identified in the United Kingdom and South Africa. And there's debate among testing experts on whether wider use of cheaper but less sensitive rapid tests will be the smartest path out of the pandemic.
Boom ...! FDA - Approval for EUA -US Distribution list
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/notifications-and-emergency-use-authorizations-faqs-testing-sars-cov-2
This will re-rate soon it is getting investors attention now.
Ask yourself has others (ODX, AVCT) have any orders or approval the answer going to be NO.
Why have they got massive market cap?
Why are their stock prices rising without any orders?
Why was it mentioned in Finn Cap and FT, proactiveinvestor potential company to be considered for covid19 testing kits to meet high demand.
The demand is outstripping supply capacity.
PDYOR
I did my research on Avacta (AVCT), Novacyte (NCYT), Omega Diagnostics (ODX), genedrive (GDR).
1 - Genedrive - 26.54 - 1.06M - the Best opportunity - No orders - waiting for approval - still low - multibagger
2 - Omega - 212.26 - 8.51M I already have a position. - No orders - waiting for approval
3 Avacta - 376.45 - 3.20M - Price Too high & MC too high - No orders - waiting for approval
4 Novacyt - 794.78 - TBC - Too high for me
Https://www.pharmiweb.com/press-release/2021-01-21/covid-19-testing-sector-demand-set-to-continue-amid-vaccine-rollout
WOW 55p - 30%
WOW - up 24% to 52p
Not selling any of my shares until £3+
Tell them to sell quickly - the shares are in high demand. -
Volume: 1,954,459
Second Price Monitoring Extn
They cannot handle the volume.
People are going crazy to buy on the news.
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Look at NCYT when from 14p to £10+
This is our turn to rocket now.
WOW . Price still at 51p
Volume: 1,755,266
You, sad people, keep watching this rise to £3.
You keep on deramping - people can see through you guys.
Everybody can read and can do their own research.
This isn't a ramp, see the news. the GDR is flying today. It has dropped from £3 for no reason.
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Biden’s plan calls for a newly created Pandemic Testing Board to coordinate a “clear, unified approach” to testing for COVID-19, a marked difference from the Trump administration’s policy of states establishing their own plans with federal support.
Laboratories have ramped up production to more than 2 million tests each day, but stubborn problems persist. Some labs struggle to complete timely tests – particularly when demand surges – because of shortages of critical supplies.
Public health labs largely are not equipped to detect new coronavirus variants such as ones first identified in the United Kingdom and South Africa. And there's debate among testing experts on whether wider use of cheaper but less sensitive rapid tests will be the smartest path out of the pandemic.
Order news must have been leaked...?
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Biden’s plan calls for a newly created Pandemic Testing Board to coordinate a “clear, unified approach” to testing for COVID-19, a marked difference from the Trump administration’s policy of states establishing their own plans with federal support.
Laboratories have ramped up production to more than 2 million tests each day, but stubborn problems persist. Some labs struggle to complete timely tests – particularly when demand surges – because of shortages of critical supplies.
Public health labs largely are not equipped to detect new coronavirus variants such as ones first identified in the United Kingdom and South Africa. And there's debate among testing experts on whether wider use of cheaper but less sensitive rapid tests will be the smartest path out of the pandemic.